Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Overactive Bladder Syndrome

Treatments

Drug: Solifenacin

Study type

Interventional

Funder types

Other

Identifiers

NCT01627145
201012024RC

Details and patient eligibility

About

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.

Enrollment

300 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

female patients within 18 years old to 99 years old with overactive bladder syndrome

Exclusion criteria

unwilling or unable to perform testing procedure

Trial design

300 participants in 1 patient group

antimuscariniz drug
Experimental group
Treatment:
Drug: Solifenacin

Trial contacts and locations

0

Loading...

Central trial contact

Ho-Hsiung Lin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems